Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3760/cma.j.cn112147-20200315-00339 http://scihub22266oqcxt.onion/10.3760/cma.j.cn112147-20200315-00339 32198915!ä!32198915 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Zhonghua+Jie+He+He+Hu+Xi+Za+Zhi 2020 ; 43 (8): 633-638 Nephropedia Template TP {{tp|p=32198915|t=2020. When COVID-19 encounters interstitial lung disease: challenges and management |pdf=|usr=}}{{32198915}} gab.com Text When COVID-19 encounters interstitial lung disease: challenges and management JO: Zhonghua Jie He He Hu Xi Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32198915 #FOAvip In December 2019, a new type of coronavirus pneumonia (COVID-19) emerged in Wuhan, Hubei, and spread rapidly to China. The lung injury and repair caused by COVID-19 has many similarities with the onset and progression of interstitial lung disease (ILD) . Therefore, it is difficult to distinguish between COVID-19 and some types of new-onset ILD or other causes leading to acute exacerbation of ILD. Clinicians need to comprehensively analyze the epidemic history, disease onset characteristics, clinical manifestations, image characteristics, serological andpathogenic microorganism test results to confirm diagnosis. Because of this, the article will discuss the issues related to the differential diagnosis and management of COVID-19 and ILD, and try to provide reasonable suggestions. Twit Text FOAVip When COVID-19 encounters interstitial lung disease: challenges and management ????Zhonghua Jie He He Hu Xi Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32198915 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32198915 #FOAvip English Wikipedia <ref>{{Cite pmid|32198915}}</ref> When COVID-19 encounters interstitial lung disease: challenges and management #MMPMID32198915 Ren YH; Wang SY; Liu M; Guo YM; Dai HP Zhonghua Jie He He Hu Xi Za Zhi 2020[Aug]; 43 (8): 633-638 PMID32198915show ga In December 2019, a new type of coronavirus pneumonia (COVID-19) emerged in Wuhan, Hubei, and spread rapidly to China. The lung injury and repair caused by COVID-19 has many similarities with the onset and progression of interstitial lung disease (ILD) . Therefore, it is difficult to distinguish between COVID-19 and some types of new-onset ILD or other causes leading to acute exacerbation of ILD. Clinicians need to comprehensively analyze the epidemic history, disease onset characteristics, clinical manifestations, image characteristics, serological andpathogenic microorganism test results to confirm diagnosis. Because of this, the article will discuss the issues related to the differential diagnosis and management of COVID-19 and ILD, and try to provide reasonable suggestions. |*Betacoronavirus[MESH] |*Coronavirus Infections/epidemiology[MESH] |*Pneumonia, Viral/epidemiology[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Humans[MESH] |Lung Diseases, Interstitial/*complications/diagnosis/*therapy[MESH] |Pandemics[MESH] When COVID-19 encounters interstitial lung disease: challenges and ma(epmc).pdf DeepDyve Pubget Overpricing